Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3 (DEFUSE 3)
Sponsor: Gregory W Albers
Terminated
Interim analysis showed a high likelihood of benefit in the endovascular group
Other Cerebral Infarction trials with similar outcome
A NA clinical study on Cerebral Infarction and Stroke, Acute, this trial is terminated or withdrawn. The trial is conducted by Gregory W Albers and has accumulated 12 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2019 — Jan 2021 [monthly]
Terminated NA
▶ Show 7 earlier versions
-
Oct 2018 — Jun 2019 [monthly]
Terminated NA
-
Jun 2018 — Oct 2018 [monthly]
Terminated NA
-
Dec 2017 — Jun 2018 [monthly]
Terminated NA
-
Sep 2017 — Dec 2017 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
May 2017 — Sep 2017 [monthly]
Recruiting NA
-
Feb 2017 — May 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gregory W Albers
- Medical University of South Carolina
- NINDS Stroke Trials Network (StrokeNet)
- National Institute of Neurological Disorders and Stroke (NINDS)
- University of Cincinnati
For direct contact, visit the study record on ClinicalTrials.gov .